Poor treatment outcome and its predictors among drug-resistant tuberculosis patients in Ethiopia: A systematic review and meta-analysis

被引:25
|
作者
Alemu, Ayinalem [1 ]
Bitew, Zebenay Workneh [2 ]
Worku, Teshager [3 ]
机构
[1] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia
[2] St Pauls Hosp, Millennium Med Coll, Addis Ababa, Ethiopia
[3] Haramaya Univ, Coll Hlth & Med Sci, Harar, Ethiopia
关键词
Drug-resistant; Ethiopia; Multi-drug resistant tuberculosis; TREATMENT SUCCESS; RISK-FACTORS; MORTALITY; SURVIVAL; TB; CARE; COHORT; DEATH;
D O I
10.1016/j.ijid.2020.05.087
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: To assess poor treatment outcomes and their predictors among drug-resistant tuberculosis patients treated in Ethiopia. Methods: Data were searched from both electronic databases and other sources. From the whole search, 404 articles were reviewed and 17 articles that fulfilled the inclusion criteria were included in the analysis. Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist was followed and Joanna Briggs Institute Critical Appraisal checklist was used for assessing the quality. Risk of bias was assessed using forest plot and Egger's regression test. Data were analyzed using STATA version 15 and Review Manager Software version 5.3. Results: The overall pooled proportion of poor treatment outcome and mortality was 17.86% and 15.13% respectively. The incidence density rate of poor treatment outcome and mortality was 10.41/1000 person-months and 9.28/1000 person-months respectively. Survival status and successful treatment outcomes were 76.97% and 63.82% respectively. HIV positivity, non-HIV comorbidities, clinical complications, extrapulmonary involvement, undernutrition, anemia, treatment delay, lower body weight, and older age were the predictors of poor treatment outcome. Conclusion: Better survival and treatment success rates were noted in Ethiopia as compared to the global average. The majority of the poor treatment outcomes occurred within the intensive phase. Early initiation of anti-tuberculosis treatment would be important for successful treatment outcomes. (C) 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
引用
收藏
页码:420 / 439
页数:20
相关论文
共 50 条
  • [1] Predictors of mortality in patients with drug-resistant tuberculosis: A systematic review and meta-analysis
    Alemu, Ayinalem
    Bitew, Zebenay Workneh
    Worku, Teshager
    Gamtesa, Dinka Fikadu
    Alebel, Animut
    [J]. PLOS ONE, 2021, 16 (06):
  • [2] Treatment Outcomes among Patients with Extensively Drug-Resistant Tuberculosis: Systematic Review and Meta-Analysis
    Jacobson, Karen R.
    Tierney, Dylan B.
    Jeon, Christie Y.
    Mitnick, Carole D.
    Murray, Megan B.
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 51 (01) : 6 - 14
  • [3] Drug-Resistant Tuberculosis Among Children: A Systematic Review and Meta-Analysis
    Song, Wan-mei
    Li, Yi-fan
    Liu, Yun-xia
    Liu, Yao
    Yu, Chun-bao
    Liu, Jin-yue
    Li, Huai-chen
    [J]. FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [4] Bedaquiline and delamanid treatment outcomes among patients with drug-resistant tuberculosis: a systematic review and meta-analysis
    Heidari, Hamid
    Moradkasani, Safoura
    Ghanavati, Roya
    Kalantar-neyestanaki, Mahshid
    Kouhsari, Ebrahim
    Ghafourian, Sobhan
    Feyisa, Seifu Gizaw
    Kazemian, Hossein
    [J]. MINERVA RESPIRATORY MEDICINE, 2024, 63 (01): : 16 - 24
  • [5] Risk factors associated with drug-resistant tuberculosis in Ethiopia: A systematic review and meta-analysis
    Alemu, Ayinalem
    Bitew, Zebenay Workneh
    Diriba, Getu
    Gumi, Balako
    [J]. TRANSBOUNDARY AND EMERGING DISEASES, 2022, 69 (05) : 2559 - 2572
  • [6] Prevalence of tuberculosis infection among contacts of drug-resistant tuberculosis patients: A systematic review and meta-analysis
    Akalu, Temesgen Yihunie
    Clements, Archie C. A.
    Gebreyohannes, Eyob Alemayehu
    Gilmour, Beth
    Alene, Kefyalew Addis
    [J]. JOURNAL OF INFECTION, 2024, 89 (02)
  • [7] Epidemiology of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis
    Diriba, Getu
    Alemu, Ayinalem
    Yenew, Bazezew
    Tola, Habteyes Hailu
    Gamtesa, Dinka Fikadu
    Mollalign, Hilina
    Eshetu, Kirubel
    Moga, Shewki
    Abdella, Saro
    Tollera, Getachew
    Kebede, Abebaw
    Dangisso, Mesay Hailu
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 132 : 50 - 63
  • [8] Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis
    Dey, Teesta
    Brigden, Grania
    Cox, Helen
    Shubber, Zara
    Cooke, Graham
    Ford, Nathan
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (02) : 284 - 293
  • [9] Efficacy of bedaquiline in the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis
    Wang, Ming-Gui
    Wu, Shou-Quan
    He, Jian-Qing
    [J]. BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [10] Linezolid for the treatment of extensively drug-resistant tuberculosis: a systematic review and meta-analysis
    Lifan, Z.
    Sainan, B.
    Feng, S.
    Siyan, Z.
    Xiaoqing, L.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2019, 23 (12) : 1293 - 1307